Treatment Interruption and Regimen Change in Firstgeneration versus Second-generation Tyrosine Kinase Inhibitors used as First-line Therapy for Chronic Myeloid Leukemia

Background: Research has shown that treatment interruptions are associated with worse failure-free survival in chronic myeloid leukemia (CML); however they are commonly used in clinical trials to manage adverse events. Objectives: This study assessed the comparative rates of treatment interruption a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Melea A., Fang, Gang, Richards, Kristy L., Walko, Christine M., Earnshaw, Stephanie R., Happe, Laura E., Blalock, Susan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2015
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471360/
https://www.ncbi.nlm.nih.gov/pubmed/37663584
http://dx.doi.org/10.36469/9899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471360/
https://www.ncbi.nlm.nih.gov/pubmed/37663584
http://dx.doi.org/10.36469/9899

Ejemplares similares